CLINICAL CHARACTERISTICS OF LATE-ONSET NEUROMYELITIS OPTICA SPECTRUM DISORDER
Main Article Content
Abstract
Objective: To describe the clinical characteristics of late-onset neuromyelitis optica spectrum disorder (LO-NMOSD). Methods: This study included 51 patients aged ≥50 years who were diagnosed with NMOSD and treated at Bach Mai Hospital and Hanoi Medical University Hospital. Results: The disease predominantly affected females (88.2%), with a female-to-male ratio of approximately 7:1 (45/6, p < 0.05). The mean age at onset was 60.0 ± 7.7 years, and 41.2% of patients experienced relapses. All patients developed symptoms within the first month of onset. Motor weakness was observed in 52.9%, sensory disturbances in 58.8%, sphincter dysfunction in 47.1%, blurred vision in 47.1%, persistent nausea and vomiting in 9.8%, and cranial nerve palsy in 2%. The major clinical syndromes included acute transverse myelitis (68.6%), optic neuritis (52.9%), area postrema syndrome (5.9%), and acute brainstem syndrome (2%). Patients with an Expanded Disability Status Scale (EDSS) score ≥6, indicating the need for assistance in ambulation, accounted for 58.8%, with a mean EDSS of 6 ± 2.5. Conclusion: Patients with LO-NMOSD commonly presented with spinal cord, optic nerve, and brainstem involvement, and exhibited a high level of disability.
Article Details
Keywords
Late-Onset Neuromyelitis Optica Spectrum Disorder (LO-NMOSD)
References
2. Palace J, Lin DY, Zeng D, et al. Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders. Brain. 2019;142(5):1310–1323.
3. Fragoso YD, Ruocco HH, Dias RM, et al. Late onset of neuromyelitis optica spectrum disorders. Neurol Ther. 2019. Epub ahead of print. doi:10.1007/s40120-019-0143-2.
4. Seok JM, Cho HJ, Ahn SW, et al. Clinical characteristics of late-onset neuromyelitis optica spectrum. Mult Scler. 2017;23(13):1748–1756.
5. Cree BA, Hauser SL. Neuromyelitis optica. In Harrison’s Principles of Internal Medicine. 20th ed. New York: McGraw-Hill Education; 2018. Chapter 437.
6. Carnero Contentti E, Daccach Marques V, Soto de Castillo I, et al. Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohort. J Neurol. 2020;267:1260–1268.
7. Mealy MA, Levy M, Schmidt F, et al. Diagnostic delay in neuromyelitis optica spectrum disorders: Patient journey and real-world barriers. Front Neurol. 2022;13:866442. doi:10.3389/ fneur.2022.866442.